Verve Therapeutics Inc
VERV
Market Cap$1.01B
Close$
$1.52
86.6% downside
Current Fair Value
86.6% downsideOvervalued by 86.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.01 Billion |
|---|---|
| Enterprise Value | $1.00 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.36 |
| Beta | 1.68 |
| Outstanding Shares | 88,796,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.41 |
|---|---|
| PEG | 14.9 |
| Price to Sales | - |
| Price to Book Ratio | 2.26 |
| Enterprise Value to Revenue | 16.81 |
| Enterprise Value to EBIT | -4.77 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Verve Therapeutics Inc
63 employees